Clinical trials
Gastric or Gastroesophageal Junction Adenocarcinoma clinical trials
Below are recruiting gastric or gastroesophageal junction adenocarcinoma clinical trials, each written for real people, not researchers. We’re tracking 962 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06054906RecruitingPhase 2
Immunotherapy plus chemo before surgery for stomach cancer
This trial tests a combination of an immunotherapy drug (sintilimab) and a low-dose weekly chemotherapy regimen before surgery for locally advanced stomach cancer that can be removed. The goal is to see if this approach helps shrink the tumor and improve outcomes.
ShanghaiAges 18 years+ - NCT06202105Recruiting
Laparoscopic vs open total gastrectomy for advanced stomach cancer
This trial compares two types of surgery for stomach cancer that has grown into deeper layers but has not spread to distant organs. The goal is to see if a keyhole (laparoscopic) approach is as safe and effective as traditional open surgery.
Bien Hoa, Dong NaiAges 18–80 - NCT05344339Recruiting
Compare two stomach reconstruction methods after stomach cancer surgery
This study compares two surgical reconstruction techniques after a distal gastrectomy (removing the lower part of the stomach) for gastric (stomach) cancer. It may help find which method leads to better recovery and outcomes after surgery.
Ho Chi Minh CityAges 18–80 - NCT07517419Enrolling by invitationPhase 2
Pressurized chemotherapy for gastric cancer spread in abdomen
This trial tests a specialized chemotherapy delivery method called PIPAC—where chemotherapy is sprayed directly into the abdomen under pressure—for patients with gastric cancer that has spread to the abdominal lining. The goal is to deliver stronger doses of chemotherapy directly to where the cancer is, potentially helping patients who aren't candidates for major surgery.
Hong KongAges 18–80 - NCT07517432Recruiting
Registry tracking robotic surgery outcomes in gastric cancer
This study follows patients with stomach cancer who have robotic-assisted surgery to understand how well this advanced surgical approach works. By collecting information from multiple hospitals worldwide, researchers can learn what outcomes patients experience and how to improve care.
Hong KongAges Any age - NCT07509008RecruitingPhase 1/Phase 2
Immune cells in the belly for stomach cancer spread
This trial tests a new type of immune cell (called a CAR NK cell) given directly into the belly, along with standard surgery and chemotherapy, for stomach cancer that has spread to the belly lining. The goal is to see if this treatment is safe and can help control the cancer.
Houston, TexasAges 18 years+ - NCT07505927Recruiting
Acupuncture for slow stomach emptying after stomach surgery
This study tests whether acupuncture can help improve slow stomach emptying that sometimes happens after partial stomach removal surgery. It's for people who have this specific problem and want to try a non-drug option.
Jinan, ShandongAges 18–80 - NCT07506356Recruiting
Stomach emptying in diabetes patients on GLP-1 drugs
This study uses an ultrasound to check how fast your stomach empties food. It looks at people with type 2 diabetes who have been taking a GLP-1 medication for at least three months.
Geneva, Canton of GenevaAges 18 years+ - NCT06767449Recruiting
Zolbetuximab for Claudin18.2 positive stomach cancer
This trial is for people with advanced stomach cancer that has a specific protein called Claudin18.2 and is HER2-negative. It tests whether continuing zolbetuximab—a drug that targets this protein—can help control the cancer.
SeoulAges 19 years+ - NCT06767436Recruiting
Real-world study of Enhertu for advanced gastric cancer
This study looks at how well the drug Trastuzumab Deruxtecan works and how safe it is in real-world patients with advanced stomach or gastroesophageal cancer whose tumors are HER2-positive. The goal is to gather more information beyond what was learned in clinical trials.
Seoul, SeoulAges 19 years+ - NCT06422793Recruiting
Does a stomach tube reduce nausea after jaw surgery?
This study tests whether using a thin tube through the nose into the stomach during jaw surgery helps reduce nausea and vomiting after the operation. It's for people having certain types of jaw surgery to correct bite or facial problems.
Halifax, Nova ScotiaAges 16 years+ - NCT07488611RecruitingPhase 3
Progain nutrition program for stomach cancer surgery
This study tests a nutrition program (PROGAIN) for people having surgery for stomach cancer. The goal is to see if it helps with recovery.
Cheonan, Chungcheongnam-doAges 19 years+ - NCT07488312Enrolling by invitationPhase 1
Leucine-restricted diet for gastric cancer patients
This trial tests if a diet low in leucine (an amino acid) can help treat gastric cancer before surgery. It aims to see if it's safe and effective for patients who are preparing for tumor removal.
Jinan, ShandongAges 18–70 - NCT06306755Recruiting
Risk-based screening for esophageal and gastric cancer
This study tests a new way of screening for esophagus and stomach cancer by using a risk-based approach. It aims to see if this works better than standard screening, and is offered to people in certain villages in China.
Beijing, Beijing MunicipalityAges 50–69 - NCT06791083RecruitingPhase 2
Envafolimab, Fruquintinib, and chemo before gastric cancer surgery
This trial tests a combination of two targeted drugs (Envafolimab and Fruquintinib) plus chemotherapy given before surgery for certain types of stomach cancer. The goal is to see if this approach can shrink the tumor and improve outcomes.
Fuzhou, FujianAges 18–75 - NCT06792162RecruitingPhase 2
Immunotherapy and targeted therapy trial for advanced gastric cancer
This trial tests a combination of two drugs: carilizumab (an immunotherapy) and apatinib (a targeted therapy) for patients with unresectable stage III or IV gastric cancer that has a specific DNA repair problem (dMMR). The goal is to see if this treatment can help shrink tumors and improve outcomes.
BeijingAges 18 years+ - NCT07451470Recruiting
Comparing two airway devices for stomach air in children during short surgeries
This trial compares two devices used to help children breathe during surgery (LarySeal Pro and Ambu AuraGain). It measures how much air gets into the stomach, which can cause discomfort. It is for children aged 6–12 having short elective surgeries (1 hour or less).
Cairo, Cairo GovernorateAges 6–10 - NCT07436013Recruiting
Comparing two types of weight-loss revision surgery after sleeve gastrectomy
This trial compares two surgical options for people who have regained weight or didn't lose enough after a sleeve gastrectomy. It tests whether adding a ring to the standard revision surgery helps with long-term weight loss.
Alexandria, Alexandria GovernorateAges 18–65 - NCT07441850Recruiting
Digital rehab for stomach cancer patients after chemo or radiation
This trial is testing a smartphone-based exercise and recovery program for people with stomach cancer who have had chemo or radiation before surgery. It aims to help you get back on your feet faster after surgery.
BeijingAges 18–70 - NCT07444099Enrolling by invitation
Early treatment after surgery for stomach cancer patients
This trial tests an early treatment plan after stomach cancer surgery. It is for people who completed chemotherapy before surgery without serious side effects and had a short hospital stay.
Jinan, ShandongAges 18–80 - NCT06055387Recruiting
Frailty care for older stomach cancer patients after surgery
This study tests a frailty assessment and intervention program for people aged 65+ with stage II or III stomach cancer who will have surgery and chemotherapy afterward. It aims to improve recovery and quality of life.
Taoyuan, TaiwanAges 65 years+ - NCT07415616Enrolling by invitation
Cold vs warm tube feeding and stomach emptying in ICU
This study compares giving liquid food at room temperature (cold) versus body temperature (warm) through a feeding tube to see which helps the stomach empty better in ICU patients. It may help find a way to improve comfort and nutrition for people who need tube feeding.
BursaAges 18 years+ - NCT07407530Recruiting
Sipping fluids before planned c-section
This trial tests whether drinking small amounts of clear fluids up until surgery is safe for women having a planned c-section. It uses an ultrasound to check the stomach before the procedure.
Dublin, Ireland/County DublinAges 18 years+ - NCT06821776Recruiting
Comparing feeding methods for infants with severe lung disease
This study compares two ways of feeding infants with severe bronchopulmonary dysplasia (a chronic lung condition in premature babies) to see which helps with feeding problems such as reflux or aspiration. Infants will try both methods at different times to find out which works best.
Memphis, TennesseeAges 1 month–1 year
Hear when a new Gastric or Gastroesophageal Junction Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for gastric or gastroesophageal junction adenocarcinoma?
- Yes. Clin2 currently lists 962 recruiting gastric or gastroesophageal junction adenocarcinoma studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a gastric or gastroesophageal junction adenocarcinoma trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a gastric or gastroesophageal junction adenocarcinoma trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
- Gastric / Gastroesophageal Junction Adenocarcinoma
- AFP Gastric or Gastroesophageal Junction Adenocarcinoma
- Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
- Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
- Gastroesophageal Junction Adenocarcinoma
- Metastatic Gastroesophageal Junction Adenocarcinoma
- Gastroesophageal Junction (GEJ) Adenocarcinoma
- Advanced Gastroesophageal Junction Adenocarcinoma
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.